DETAILS, FICTION AND WHO MAKES COPYRIGHT SEMAGLUTIDE

San Diego-based mostly Viking Therapeutics marked itself as a serious competitor in the weight loss drug market in February after revealing promising data from a mid-phase trial of experimental drug VK2735, which instructed it rivaled—and outperformed—Novo and Lilly drugs when presented to be a weekly injection and in March the company unveiled